Big news for seniors: A new Medicare program will cover popular GLP-1 weight-loss drugs like Wegovy starting July 2026. Learn ...

The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.

The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...

CMS pauses weight-loss BALANCE model for Medicare Part D after insufficient plan sponsor participation, while Medicaid pilot continues.